Globus Medical (GMED)
(Delayed Data from NYSE)
$57.84 USD
-0.40 (-0.69%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $57.82 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
GMED 57.84 -0.40(-0.69%)
Will GMED be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMED
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?
Other News for GMED
GMED forms Stochastic Buy Signal on September 15
Insider Sell: Ann Rhoads Sells 10,000 Shares of Globus Medical Inc (GMED)
GMED falls 1.48% on September 12, leaving the technical picture intact
Bullish Engulfing appears for GMED after 2.02% move
NR7 appears for GMED after 1.08% move